Tech Company Financing Transactions
Naryx Pharma Funding Round
Naryx Pharma, based in Carpinteria, secured $8 million from Vivo Capital and Sutter Hill Ventures.
Transaction Overview
Company Name
Announced On
5/22/2006
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Investors
Vivo Capital (Lead Investor) (Chen Yu)
Proceeds Purpose
We are excited to leverage this financing to move forward in developing our lead products.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
5464 Carpinteria Ave. A
Carpinteria, CA 93013
USA
Carpinteria, CA 93013
USA
Phone
Website
Email Address
Overview
Naryx Pharma is a specialty pharmaceutical company that is developing promising propriety medication formulations for the FDA approval process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robin Campbell
Chief Financial Officer
Tim Immel
Vice President
Kimberly Salgado
VP - Operations
Andy Strayer
Browse more venture capital transactions:
Prev: 5/22/2006: Bebo venture capital transaction
Next: 5/22/2006: Kace Networks venture capital transaction
Share this article
Where The Data Comes From
We document all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs